BerGenBio ASA's total assets for Q4 2024 were kr155.80M, a decrease of -20.00% from the previous quarter. BRRGF total liabilities were kr33.09M for the fiscal quarter, a -19.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.